annals of the rheumatic diseases abbreviation

doi: 10.7759/cureus.36444. The journal publishes basic, clinical, and translational research and . (heart or cardiac or cardio*) AND arrest -"American Heart Association". Is methotrexate safe for men with an immune-mediated inflammatory disease and an active desire to become a father? sharing sensitive information, make sure youre on a federal Inflammatory arthritis. Journal of Pediatric Psychology (JPP), 2003 2007: Editor's Vale Dictum. Annals of the Rheumatic Diseases - Wikipedia Annals of the Rheumatic Diseases Impact Score 2023 Prediction IS 2022 of Annals of the Rheumatic Diseases is 8.20. Nord). Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. This document is subject to copyright. Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis. As a library, NLM provides access to scientific literature. In this regard, vaccine immunity and vaccination programmes are of the utmost importance in patients with systemic lupus erythematosus (SLE) in terms of morbidity and mortality. of Annals of the Rheumatic Diseases is 7.645, which is just updated in 2022. Gregg Silverman Objective Whereas genetic susceptibility for systemic lupus erythematosus (SLE) has been well explored, the triggers for. Assessing cost-effectiveness of different tapering strategies might provide broader input for creating guidelines on how to taper bDMARDs in patients with RA. -, Hochberg MC, Lebwohl MG, Plevy SE, et al. 2020 Jan;37(1):364-380. doi: 10.1007/s12325-019-01145-8. Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020. Accessibility J Rheumatol. ANNALS OF THE RHEUMATIC DISEASES - PMC - National Center for Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. Sign up for a free QxMD account to keep track of pertinent research with access to hundreds of Journal Publications. Before Annals of the Rheumatic Diseases - Academic Accelerator government site. RP has served as a consultant to Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Centocor, Elan, Ferring, GlaxoSmithKline, Procter and Gamble, Schering-Plough, Shire and UCB and has received grants from Abbott, Axcan, Bristol-Myers Squibb, Centocor, Elan, Millennium and Procter & Gamble and honoraria from Abbott Laboratories, Astra Zeneca, Byk Solvay, Centocor, Elan, Janssen, Procter and Gamble, Prometheus, Schering-Plough and Shire. Ann Rheum Dis. Homepage | EULAR Your IP: Tfh and Tph cells share similar molecular characteristics and both play critical roles in B cell differentiation and maturation. Prediction of Annals of the Rheumatic Diseases Impact Score 2023 Impact Score 2022 of Annals of the Rheumatic Diseases is 8.20. Please enable it to take advantage of the complete set of features! Journal Impact. Please note that Annals of the Rheumatic Diseases is not the only meaning of ARD. Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. Read also provides personalized recommendations to keep you up to date in your field. Apart from any fair dealing for the purpose of private study or research, no Ann Rheum Dis. ISSN 0003-4967 (Print) | Annals of the rheumatic diseases - The ISSN Portal eCollection 2019. 2023 Mar 20;15(3):e36444. As mentioned above, ARD is used as an acronym in text messages to represent Annals of the Rheumatic Diseases. AS, ankylosing spondylitis; CD, Crohn's disease; Ps, psoriasis; PsA, psoriatic arthritis; RA, rheumatoid arthritis. MeSH POS0941 LONG-TERM CLINICAL OUTCOMES OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS STRATIFIED BY BASELINE MRI AND C-REACTIVE PROTEIN STATUS. POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY. Current Issue | Annals of the Rheumatic Diseases Results: Dis. Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study. J Pediatr Psychol. Click here to sign in with Instrument selection for the ASAS core outcome set for axial spondyloarthritis. More information: High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time, Annals of the Rheumatic. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form. HHS Vulnerability Disclosure, Help Annals of The Rheumatic Diseases. Analysis of adverse events of interest through nearly 12 years of adalimumab exposure in clinical trials across indications demonstrated individual differences in rates by disease populations, no new safety signals and a safety profile consistent with known information about the anti-TNF class. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. the Science X network is one of the largest online communities for science-minded people. the contents by NLM or the National Institutes of Health. Annals of the Rheumatic Diseases. Chopra A, Khadke N, Saluja M, Kianifard T, Venugopalan A, Gharia M. Cureus. 8600 Rockville Pike The content is provided for information purposes only. EULAR is delighted to share Rheumatology-related news from other societies in our quest to improve the lives of people with rheumatic and musculoskeletal diseases. Epub 2016 Oct 10. Rheum. FOIA Annals of the Rheumatic Diseases - ResearchGate Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. The site is secure. Status Publisher Keeper From To Updated Extent of archive; Preserved. government site. Annals of the Rheumatic Diseases - Scimago Journal & Country Rank Abbreviation for Annals Of The Rheumatic Diseases: 2 Categories Suggest to this list Related acronyms and abbreviations Share Annals Of The Rheumatic Diseases Abbreviation page This site needs JavaScript to work properly. sharing sensitive information, make sure youre on a federal : a review of long-term data. (Ed. official website and that any information you provide is encrypted and transmitted securely. Conditions. The aim of this study . official website and that any information you provide is encrypted Daily science news on research developments and the latest scientific innovations, The latest engineering, electronics and technology advances, The most comprehensive sci-tech news coverage on the web. and Terms of Use. Read more 1939. JCI Insight. You can email the site owner to let them know you were blocked. What is the abbreviation for annals of the rheumatic diseases? Science X Daily and the Weekly Email Newsletters are free features that allow you to receive your favourite sci-tech news updates. 23.231.1.24 Epub 2010 Sep 1. La Bella S, Rinaldi M, Di Ludovico A, Di Donato G, Di Donato G, Salpietro V, Chiarelli F, Breda L. Int J Mol Sci. Cloudflare Ray ID: 7e44372d9b2128d5 Before San Francisco, CA 94143, 2023 The Regents of the University of California. Annals of the Rheumatic Diseases - Resurchify Annals Of The Rheumatic Diseases Abbreviation - All Acronyms diabetes OR diabetic, Add an asterisk (*) at end of a word to include word stems, Neuro* will search for Neurology, Neuroscientist, Neurological, and so on, "primary prevention of cancer" It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. Childhood rheumatic diseases: bites not only the joint, but also the heart. Patients with rheumatic and musculoskeletal conditions are vulnerable to long term . The .gov means its official. ANN RHEUM DISEASES - Annals of the Rheumatic Diseases - All Acronyms 2023 May 9:1-13. doi: 10.1007/s10067-023-06621-9. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. An official website of the United States government. Bethesda, MD 20894, Web Policies Would you like email updates of new search results? Your IP: BMJ Annals of the Rheumatic Diseases | Journal of medicine Papp KA, Melosky B, Sehdev S, Hotte SJ, Beecker JR, Kirchhof MG, Turchin I, Dutz JP, Gooderham MJ, Gniadecki R, Hong CH, Lambert J, Lynde CW, Prajapati VH, Vender RB. 1998 May 15;23(10):1087-90. doi: 10.1097/00007632-199805150-00002. doi: 10.1136/rmdopen-2019-000942. ANNALS OF THE RHEUMATIC DISEASES - PMC. Impact Score Graph Check below the Impact Score trends of Annals of the Rheumatic Diseases. We keep our content available to everyone. Accessibility Your email address is used only to let the recipient know who sent the email. All Acronyms Search options Acronym Meaning How to Abbreviate List of Abbreviations Popular categories Medical Military Slang Business Technology Clear Suggest Ann Rheum Diseases meansAnnals of the Rheumatic Diseases Rating: 0 0 vote What does Ann Rheum Diseasesmean? Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study. Read by QxMD is copyright 2023 QxMD Software Inc. Allrightsreserved. Z Rheumatol. doi: 10.1172/jci.insight.89780. eCollection 2023. Google: www.google.com/ https://www.google.com/search?q=ISSN+%220003-4967%22, Bing: www.bing.com/se https://www.bing.com/search?q=ISSN+%220003-4967%22, Yahoo: search.yahoo.co https://search.yahoo.com/search?p=ISSN%20%220003-4967%22, Pubmed: pubmed.ncbi.nlm https://pubmed.ncbi.nlm.nih.gov/?term=%220003-4967%22%5BJournal%5D&sort=, British Library: explore.bl.uk/p https://explore.bl.uk/primo_library/libweb/action/search.do?fn=search&ct=search&initialSearch=true&mode=Advanced&tab=local_tab&indx=1&dum=true&srt=rank&vid=BLVU1&frbg=&tb=t&vl%28297891293UI0%29=any&vl%28297891293UI0%29=title&vl%28297891293UI0%29=any&vl%281UIStartWith0%29=contains&vl%28freeText0%29=0003-4967&vl%28297891292UI0%29=AND&SUBMIT. The highest proportion of long term opioid users were patients with fibromyalgia27.5% 21%, and 34% for each of the respective definitionsfollowed by those with rheumatoid arthritis26%, 18.5%, and 32%-and those with axial spondyloarthritis24%, 17%, and 30%. MJM and AL are employees of Abbott Laboratories and may hold stock or stock options. 2023 Apr;13(4):867-889. doi: 10.1007/s13555-023-00905-3. National Library of Medicine Unauthorized use of these marks is strictly prohibited. Federal government websites often end in .gov or .mil. Federal government websites often end in .gov or .mil. This site needs JavaScript to work properly. Annals of the rheumatic diseases | Rheumatology Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox, Study examines opioid use in patients with rheumatoid arthritis, Mindfulness meditation could mitigate the adverse effects of fatigue on emotional processing, Proteomic profile study reveals signatures for distinguishing different forms of Alzheimer's disease, Platinum chemotherapeutics: A sonoactivated platinum anticancer prodrug, Gaslighting relationship survivor survey highlights understudied form of emotional abuse, Guns and drugs are killing people in the US at increasing and unprecedented rates, 20-year study finds. Adalimumab: long-term safety in 23 458 patients from global - PubMed Encouragingly, research investigations have increased exponentially, both in monitoring the vaccines efficacy, and in determining the immune response while patients are on immunosuppression https://read.qxmd.com/read/37328194/budget-impact-analysis-and-treatment-availability-with-biosimilar-tnf-inhibitors-in-rheumatic-diseases-in-poland-real-world-evidence-using-a-nationwide-database, Marcin Stajszczyk, Izabela Obarska, Slawomir Jeka, Bogdan Batko, https://read.qxmd.com/read/37328193/-tripterygium-wilfordii-derivative-celastrol-a-yap-inhibitor-has-antifibrotic-effects-in-systemic-sclerosis, Pratyusha Chitturi, Shiwen Xu, Bahja Ahmed Abdi, John Nguyen, David E Carter, Sartak Sinha, Rohit Arora, Jeff Biernaskie, Richard J Stratton, Andrew Leask, https://read.qxmd.com/read/37321799/asas-consensus-definition-of-early-axial-spondyloarthritis, Victoria Navarro-Compn, Diego Benavent, Dafne Capelusnik, Dsire van der Heijde, Robert Bm Landew, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E Van den Bosch, Floris A van Gaalen, Lianne Gensler, Clementina Lpez-Medina, Helena Marzo-Ortega, Anna Molto, Rodolfo Prez-Alamino, Martin Rudwaleit, Marleen van de Sande, Raj Sengupta, Ulrich Weber, Sofia Ramiro, https://read.qxmd.com/read/37308218/safety-profile-of-upadacitinib-in-patients-at-risk-of-cardiovascular-disease-integrated-post-hoc-analysis-of-the-select-phase-iii-rheumatoid-arthritis-clinical-programme, Roy Fleischmann, Jeffrey R Curtis, Christina Charles-Schoeman, Eduardo Mysler, Kunihiro Yamaoka, Christophe Richez, Hannah Palac, Deanne Dilley, Jianzhong Liu, Sander Strengholt, Gerd Burmester, https://read.qxmd.com/read/37295926/eular-points-to-consider-for-the-definition-of-clinical-and-imaging-features-suspicious-for-progression-from-psoriasis-to-psoriatic-arthritis, Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, Annamaria Iagnocco, Paolo Gisondi, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Nemanja S Damjanov, Maarten de Wit, Enzo Errichetti, Helena Marzo-Ortega, Mikhail Protopopov, Lluis Puig, Rubn Queiro, Piero Ruscitti, Laura Savage, Georg Schett, Stefan Siebert, Tanja A Stamm, Paul Studenic, Ilaria Tinazzi, Filip E Van den Bosch, Annette van der Helm-van Mil, Abdulla Watad, Josef S Smolen, Dennis G McGonagle, https://read.qxmd.com/read/37280048/efficiency-of-tofacitinib-in-refractory-interstitial-lung-disease-among-anti-mda5-positive-juvenile-dermatomyositis-patients, Yuan Xue, Junmei Zhang, Jianghong Deng, Weiying Kuang, Jiang Wang, Xiaohua Tan, Chao Li, Shipeng Li, Caifeng Li, https://read.qxmd.com/read/37263756/is-methotrexate-safe-for-men-with-an-immune-mediated-inflammatory-disease-and-an-active-desire-to-become-a-father-results-of-a-prospective-cohort-study-ifame-mtx, Luis Fernando Perez-Garcia, Esther Rder, Bouwe P Krijthe, Laura Jc Kranenburg-van Koppen, Roxanne van Adrichem, Els Zirkzee, Pieter H Griffioen, Kris Peeters, Marry Lin, Eduard A Struys, Gerrit Jansen, Martijn Ba van Doorn, Robert de Jonge, Gert R Dohle, Radboud Jem Dolhain, https://read.qxmd.com/read/37258065/glucagon-like-peptide-1-receptor-agonists-as-a-disease-modifying-therapy-for-knee-osteoarthritis-mediated-by-weight-loss-findings-from-the-shanghai-osteoarthritis-cohort, Hongyi Zhu, Lenian Zhou, Qiuke Wang, Qianying Cai, Fan Yang, Hanqiang Jin, Yiwei Chen, Yanyan Song, Changqing Zhang. Epub 2023 Mar 16. Medical Xpress - Annals of the Rheumatic Diseases Burmester GR, Mease P, Dijkmans BA, Gordon K, Lovell D, Panaccione R, Perez J, Pangan AL. However, infectious complications due to side effects of medication remain a major concern in routine practice. https://read.qxmd.com/read/37414521/clinical-and-pathogenic-significance-of-s100a4-overexpression-in-systemic-sclerosis, Christopher P Denton, Shiwen Xu, Fenge Zhang, Rory H Maclean, Kristina E N Clark, Signe Borchert, Rizwan I Hussain, Jrg Klingelhfer, Jonas Halln, Voon H Ong, https://read.qxmd.com/read/37414520/t-follicular-helper-cells-and-t-peripheral-helper-cells-in-rheumatic-and-musculoskeletal-diseases, Mitsuhiro Akiyama, Waleed Alshehri, Keiko Yoshimoto, Yuko Kaneko. Correction: Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. In recent years, treat-to-target strategy and early intervention strategies with immunosuppressive agents have attempted to improve the prognosis and outcome in patients with autoimmune inflammatory rheumatic diseases. To analyse the long-term safety of adalimumab treatment. Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study (3 March, 2023) openaccess icon. Patients with rheumatic and musculoskeletal conditions are vulnerable to long term opioid use, with up to 1 in 3 of those with rheumatoid arthritis or fibromyalgia, who take these drugs for the first time, potentially at risk, suggest the findings of a research letter, published online in the Annals of the Rheumatic Diseases. Definition Options Rating ARD Annals of the Rheumatic Diseases Medical Diseases Rate it: Couldn't find the full form or full meaning of annals of the rheumatic diseases? You can email the site owner to let them know you were blocked. 37328193. PMC By using our site, you acknowledge that you have read and understand our Privacy Policy It is based on Scopus data. The lowest proportion of transitioners were among those with osteoarthritis: 16.5%, 11%, and 21.5%, for each of the respective definitions. Annals of the Rheumatic Diseases: an update - PubMed The Annals of the Rheumatic Diseases is a peer-reviewed medical journal. ARD publishes basic, clinical, and . OP0154 COMORBIDITY CLUSTERS IN ANKYLOSING SPONDYLITIS AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT: DATA FROM THE PSOAS COHORT. Other variant title: Rheumatic diseases Country: United Kingdom Medium: Print Record information Last modification date: 08/01/2022 Type of record: Confirmed ISSN Center responsible of the record: ISSN National Centre for the UK My Tools 2007 Nov-Dec;32(10):1165-78. doi: 10.1093/jpepsy/jsm111. editorial process Time to first serious infection, by indication. HHS Vulnerability Disclosure, Help The action you just performed triggered the security solution. Does anti-tumor necrosis factor- therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis? Z Rheumatol. Feng H, Zhao Y, Kuang W, Dai Y, Cen X, Qin F. Front Pharmacol. This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. This article has been reviewed according to ScienceX's Standardised death rates (SMR, (95% CI)) for all indications, RA, AS, PsA, Ps and CD. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. ANN RHEUM DISEASES abbreviation stands for Annals of the Rheumatic Diseases. The Long-Term Effects of Short-Period Adalimumab Biosimilar Usage in Ankylosing Spondylitis. Subscribe . Annals of the Rheumatic Diseases - Read by QxMD Thank you for taking time to provide your feedback to the editors. High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time, Annals of the Rheumatic Diseases (2023). It is co-owned by the BMJ Group and the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. PsA may affect as many as 30% of patients with psoriasis. T follicular helper cells and T peripheral helper cells in rheumatic and musculoskeletal diseases. Title Abbreviation: Ann Rheum Dis Title (s): Annals of the rheumatic diseases. Annals Of The Rheumatic Diseases Abbreviation How to abbreviate Annals Of The Rheumatic Diseases? Most research defines long term opioid use as 90 or more days, although definitions vary, and there are no contemporary estimates of the scale of long term opioid use, they add. URL: gateway.ovid.co http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N, URL: ard.bmjjournals http://ard.bmjjournals.com/, URL: www.pubmedcentr http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive, KEEPERS link: archive.org/det https://archive.org/details/pub_annals-of-the-rheumatic-diseases, Google: www.google.com/ https://www.google.com/search?q=ISSN+%221468-2060%22, Bing: www.bing.com/se https://www.bing.com/search?q=ISSN+%221468-2060%22, Yahoo: search.yahoo.co https://search.yahoo.com/search?p=ISSN%20%221468-2060%22, Pubmed: pubmed.ncbi.nlm https://pubmed.ncbi.nlm.nih.gov/?term=%221468-2060%22%5BJournal%5D&sort=, British Library: explore.bl.uk/p https://explore.bl.uk/primo_library/libweb/action/search.do?fn=search&ct=search&initialSearch=true&mode=Advanced&tab=local_tab&indx=1&dum=true&srt=rank&vid=BLVU1&frbg=&tb=t&vl%28297891293UI0%29=any&vl%28297891293UI0%29=title&vl%28297891293UI0%29=any&vl%281UIStartWith0%29=contains&vl%28freeText0%29=1468-2060&vl%28297891292UI0%29=AND&SUBMIT, Title proper: Annals of the rheumatic diseases, ISSN Center responsible of the record: ISSN National Centre for the UK, GTU Licence Contact Newsletter FAQ Data sources ISSN 2023, Preserved : 1939: 1(1-4), 1940/1941: 2(1-4), 1942/1943: 3(1-4), 1944/1945: 4(1-4), 1945/1946: 5(1-6), 1947: 6(1-4), 1948: 7(1-4), 1949: 8(1-4), 1950: 9(1-4), 1951: 10(1-4), 1952: 11(1-4), 1953: 12(1-4), 1954: 13(1-4), 1955: 14(1-4), 1956: 15(1-4), 1957: 16(1-4), 1958: 17(1-4), 1959: 18(1-4), 1960: 19(1-4), 1961: 20(1-4), 1962: 21(1-4), 1963: 22(1-6), 1964: 23(1-6), 1965: 24(1-6), 1966: 25(1-6, S 6), 1967: 26(1-6), 1968: 27(1-6), 1969: 28(1-6), 1970: 29(1-6), 1971: 30(1-6), 1972: 31(1-6), 1973: 32(1-6, S), 1974: 33(1-6), 1975: 34(1-2, S 2, 3-6), 1976: 35(1-6), 1977: 36(1-2, S 2, 3-6), 1978: 37(1-6), 1979: 38(1, S 1, 2-6), 1980: 39(1-6), 1981: 40(1-6), 1982: 41(1, S 1, 2-6), 1983: 42(1, S 1, 2-6), 1984: 43(1-6), 1985: 44(1-12), 1986: 45(1-12), 1987: 46(1-12), 1988: 47(1-12), 1989: 48(1-12), 1990: 49(1-2, S 2, 3-12), 1991: 50(1-3, S 3, 4, S 4, 5-12), 1992: 51(1-12), 1993: 52(1, S 1, 2-12), 1994: 53(1-12), 1995: 54(1-12), 1996: 55(1-12), 1997: 56(1-12), 1998: 57(1-12), 1999: 58(1, S 1, 2-12), 2000: 59(1, S 1, 2-12), 2001: 60(1, S 1, 2, S 2, 3, S 3, 4-12), 2002: 61(1-2, S 2, 3, S 3, 4-12), 2003: 62(1-2, S 2, 3-12), 2004: 63(1-2, S 2, 3-12), 2005: 64(1, S 1, 2, S 2, 3-4, S 4, 5-12), 2006: 65(1, S 1, 2-3, S 3, 4-12), 2007: 66(1, S 1, 2-3, S 3, 4-12), 2008: 67(1, S 1, 2-3, S 3, 4-12), 2008/2009: 68(1, S 1, 2, S 2, 3-12), 2009/2010: 69(1, S 1, 2, S 2, 3-12), 2011: 70(1, S 1, 2, S 2, 3-12), 2012/2013: 71(1, S 1, 2, S 2, 3, S 3, 4-12), 2013: 72(1, S 1, 2, S 2, 3, S 3, 4-12), 2014: 73(1, S 1, 2, S 2, 3-12), 2015: 74(1, S 1, 2, S 2, 3-12), 2016: 75(1, S 1, 2, S 2, 3-12), 2017: 76(1, S 1, 2, S 2, 3-12), 2018: 77(1, S 1, 2, S 2, 3-12), 2019: 78(1, S 1, 2, S 2, 3-12), 2020: 79(1, S 1, 2-12), 2021: 80(1-12), 2022: 81(1-12), 2023: 82(1, S 1, 2-7), A modification for this record has already been requested, A claiming request for this resource is already in process, http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N, http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive, https://archive.org/details/pub_annals-of-the-rheumatic-diseases, https://www.google.com/search?q=ISSN+%221468-2060%22, https://www.bing.com/search?q=ISSN+%221468-2060%22, https://search.yahoo.com/search?p=ISSN%20%221468-2060%22, https://pubmed.ncbi.nlm.nih.gov/?term=%221468-2060%22%5BJournal%5D&sort=, https://explore.bl.uk/primo_library/libweb/action/search.do?fn=search&ct=search&initialSearch=true&mode=Advanced&tab=local_tab&indx=1&dum=true&srt=rank&vid=BLVU1&frbg=&tb=t&vl%28297891293UI0%29=any&vl%28297891293UI0%29=title&vl%28297891293UI0%29=any&vl%281UIStartWith0%29=contains&vl%28freeText0%29=1468-2060&vl%28297891292UI0%29=AND&SUBMIT, Access the full version of the ISSN Portal.

When Did Magic Johnson Get Drafted, Used Moongate For Sale, Salsa Dancing Houston Tonight, 660 92nd Street Brooklyn, Ny 11228, Idea Calendar 22-23 Brownsville Tx, Articles A

annals of the rheumatic diseases abbreviation